Skip to content
Menu

Prestige Consumer Healthcare Inc. PBH

Full chart Compare
Set alert

Price alert · PBH

All alert types
48.00 USD +1.81 (+3.92%)

Regular-session close

47.99 -0.01 -0.02%

Pre-market · Nov 17, 7:31 AM ET

46.69 Day range 48.28
41.77 52-week range 71.07
YTD
-22.19%
1 year
-20.01%
Market cap
2.28B
Revenue (ttm)
1.17B
Profit margin
13.29%
EPS (ttm)
3.24
Shares out
47.40M
P/E ratio
14.81
Forward P/E
9.45
YTD return
-22.19%
1-year return
-20.01%
50-day average
47.40
Volume
531.10K
Avg volume
571.68K
Open
46.70
Previous close
46.19
Day's range
46.69 – 48.28
52-week range
41.77 – 71.07
Beta
0.29
Analysts
Buy
Price target
66.20 (+37.9%)
Earnings date
Feb 4, 2027

5D +3.92 (+9.01%)

444648TueWedThuFriMon47.45

Key statistics

200-day average
53.15
Enterprise value
4.27B
PEG ratio
1.31
Price / sales
1.95
Price / book
1.17
Revenue growth
22.70%
Free cash flow
147.57M
Total cash
46.52M
Total debt
2.13B
Return on equity
8.23%
Short % of float
10.80%

Fundamental scorecard

11 of 25 checks passed on PBH’s reported financials

ValueGrowthProfitabilityHealthDividend

11of 25 checks passed

  • Value 5 of 5
  • Growth 2 of 5
  • Profitability 2 of 5
  • Financial health 2 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
PBH Revenue — quarterly 336.31M
PBH Net income — quarterly 25.30M
PBH EPS — quarterly 0.53

Earnings

PBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20261.08———
Nov 5, 2026Sep 30, 20261.071.13+0.06+5.61%
Aug 6, 2026Jun 30, 20260.8940.98+0.09+9.62%
May 13, 2026Mar 31, 20261.391.23-0.16-11.51%
Feb 5, 2026Dec 31, 20251.161.14-0.02-1.72%
Nov 6, 2025Sep 30, 20250.971.07+0.10+10.31%

Upgrades / downgrades

PBH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026Canaccord GenuitymainBuyBuy
May 15, 2026Canaccord GenuitymainBuyBuy
May 14, 2026OppenheimerdownOutperformPerform
May 7, 2026OppenheimermainOutperformOutperform
Feb 2, 2026JefferiesmainHoldHold
Nov 7, 2025Canaccord GenuitymainBuyBuy

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

Your note

Sign in to keep a note on PBH — it syncs with the Stock Master app.

Insider holders

PBH insider holders
InsiderRelationLatest transactionDateShares held
BYOM JOHN EDirectorStock Award(Grant)Aug 3, 202654,575
CLARK CLESTEEN ADirectorStock Award(Grant)Aug 3, 202616,511
FRITZ MARY BETHOfficerStock Award(Grant)May 4, 202517,366
HOPKINS SHEILA ADirectorStock Award(Grant)Aug 4, 202530,123
LOMBARDI RONALD MChief Executive OfficerStock Award(Grant)May 3, 2026378,205
MEKHAIL ADELOfficerStock Award(Grant)May 3, 202626,190

Institution ownership

PBH institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.58%7,859,601377.65MSep 29, 2026
Ariel Investments, LLC10.50%4,975,958239.09MSep 29, 2026
Vanguard Portfolio Management LLC5.93%2,810,363135.04MSep 29, 2026
Dimensional Fund Advisors LP5.59%2,649,545127.31MSep 29, 2026
Fuller & Thaler Asset Management Inc.5.33%2,527,139121.43MSep 29, 2026
State Street Corporation4.66%2,210,977106.24MSep 29, 2026

Fund ownership

PBH fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%2,820,031135.50MSep 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.3.93%1,862,01489.47MJun 29, 2026
Ariel Investment Trust-Ariel Fund3.59%1,703,53281.85MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%1,509,36872.53MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.61%1,236,62859.42MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%1,085,72852.17MJun 29, 2026